The association of elective hormone therapy with changes in lipids among glucose intolerant postmenopausal women in the diabetes prevention program
Sherita Hill Golden, Catherine Kim, Elizabeth Barrett‐Connor et al. · Metabolism · 2013
Cited by 7 works. doi:10.1016/j.metabol.2013.04.005
Authors
References
- Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
- Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol.
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy
- Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women
- Estrogen plus Progestin and the Risk of Coronary Heart Disease
- Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
- Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis